Skip to content

Study · Randomized controlled trial · n = 103 · 1988

4 results

Glucagon-induced small bowel air reflux: degrading effects on double-contrast colon examination.

Stone EE, Conte FA

Gastrointestinal radiology1 Jul 1988Cited by 2 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study4

4 results from studies that gave the peptide. 4 results from people.

  1. 01HumanRandomized controlled trialOther

    In patients undergoing barium enema, glucagon increased small bowel air compared with no glucagon.

    In plain wordsIn patients undergoing barium enema, glucagon increased small bowel air compared with no glucagon.

    Peptide
    Glucagon
    Outcome
    IncreaseSmall bowel air amount
    Study

    n = 103

    Comparator
    No glucagon
    Outcome group
    Diagnostic Imaging · Gastrointestinal
    Studied dose
    0.5 mg · intravenousAs given in this study (human).

    Source sentences

    Summary
    The group receiving glucagon demonstrated an increased amount of small bowel air and a greater magnitude of change in its volume secondary to reflux, as well as degradation in the quality of barium enema study when compared to the nonglucagon group.
    2 context sentences
    Summary · context
    Glucagon-induced small bowel air reflux and its effect on the diagnostic quality of the double-contrast barium enema examination was prospectively evaluated in 103 patients.
    Summary · context
    These were randomly assigned to receive 0.5 mg intravenous glucagon (50 patients) or to a control group without such medication (53 patients).
  2. 02HumanRandomized controlled trialOther

    In patients undergoing barium enema, glucagon increased reflux-related air volume change compared with no glucagon.

    In plain wordsIn patients undergoing barium enema, glucagon increased reflux-related air volume change compared with no glucagon.

    Peptide
    Glucagon
    Outcome
    IncreaseReflux-related air volume change
    Study

    n = 103

    Comparator
    No glucagon
    Outcome group
    Diagnostic Imaging · Gastrointestinal
    Studied dose
    0.5 mg · intravenousAs given in this study (human).

    Source sentences

    Summary
    The group receiving glucagon demonstrated an increased amount of small bowel air and a greater magnitude of change in its volume secondary to reflux, as well as degradation in the quality of barium enema study when compared to the nonglucagon group.
    2 context sentences
    Summary · context
    Glucagon-induced small bowel air reflux and its effect on the diagnostic quality of the double-contrast barium enema examination was prospectively evaluated in 103 patients.
    Summary · context
    These were randomly assigned to receive 0.5 mg intravenous glucagon (50 patients) or to a control group without such medication (53 patients).
  3. 03HumanRandomized controlled trialOther

    In patients undergoing barium enema, glucagon reduced examination quality compared with no glucagon.

    In plain wordsIn patients undergoing barium enema, glucagon reduced examination quality compared with no glucagon.

    Peptide
    Glucagon
    Outcome
    DecreaseBarium enema quality
    Study

    n = 103

    Comparator
    No glucagon
    Outcome group
    Diagnostic Imaging · Gastrointestinal
    Studied dose
    0.5 mg · intravenousAs given in this study (human).

    Source sentences

    Summary
    The group receiving glucagon demonstrated an increased amount of small bowel air and a greater magnitude of change in its volume secondary to reflux, as well as degradation in the quality of barium enema study when compared to the nonglucagon group.
    2 context sentences
    Summary · context
    Glucagon-induced small bowel air reflux and its effect on the diagnostic quality of the double-contrast barium enema examination was prospectively evaluated in 103 patients.
    Summary · context
    These were randomly assigned to receive 0.5 mg intravenous glucagon (50 patients) or to a control group without such medication (53 patients).
  4. 04HumanRandomized controlled trialOther

    In patients undergoing barium enema, glucagon did not significantly improve appendix visualization compared with no glucagon.

    In plain wordsIn patients undergoing barium enema, glucagon did not significantly improve appendix visualization compared with no glucagon.

    Peptide
    Glucagon
    Outcome
    No significant changeAppendix visualization
    Study

    n = 103

    Comparator
    No glucagon
    Outcome group
    Diagnostic Imaging · Gastrointestinal
    Studied dose
    0.5 mg · intravenousAs given in this study (human).

    Source sentences

    Summary
    No significant improvement in visualization of the appendix after glucagon was observed.
    2 context sentences
    Summary · context
    Glucagon-induced small bowel air reflux and its effect on the diagnostic quality of the double-contrast barium enema examination was prospectively evaluated in 103 patients.
    Summary · context
    These were randomly assigned to receive 0.5 mg intravenous glucagon (50 patients) or to a control group without such medication (53 patients).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    28 Oct 2026, 02:03 UTC

    Study results updated

  2. Version 1

    27 Oct 2026, 16:35 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.